LIPO   $2.3  -14.81% Market Open

Lipella Pharmaceuticals Inc.
Total Cash 1.19M
totalCashPerShare 0.148
EBITDA
Total Debt 93.68K
quickRatio 2.544
currentRatio 4.332
Total Revenue 507.20K
debtToEquity 5.498
Revenue/Share 0.074
ROA -0.9377
ROE -1.71559
grossProfits
freeCashflow -2.25M
operatingCashflow -3.72M
earningsGrowth
revenueGrowth 0.279
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -6.97927
profitMargins 0.0
enterpriseValue 2.00M
forwardPE -0.973
floatShares 5.21M
sharesOutstanding 9.67M
sharesShort 174.74K
sharesShortPriorMonth 120.54K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.35%
heldPercentInstitutions 0.08%
Short Ratio help_outline 0.08%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 0.224
Price To Book help_outline 1.74
earningsQuarterlyGrowth
netIncomeToCommon -4.14M
trailingEps -0.61%
forwardEps -0.40%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 7
lastUpdated Nov. 2, 2024, 12:10 a.m.